Bingfeng Chu

522 total citations
23 papers, 395 citations indexed

About

Bingfeng Chu is a scholar working on Molecular Biology, Periodontics and Oncology. According to data from OpenAlex, Bingfeng Chu has authored 23 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Periodontics and 5 papers in Oncology. Recurrent topics in Bingfeng Chu's work include Oral microbiology and periodontitis research (6 papers), RNA Interference and Gene Delivery (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Bingfeng Chu is often cited by papers focused on Oral microbiology and periodontitis research (6 papers), RNA Interference and Gene Delivery (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Bingfeng Chu collaborates with scholars based in China, Canada and Philippines. Bingfeng Chu's co-authors include Daxiang Cui, G. Hu, Rong He, Tuo Huang, Feng Gao, Ping Xu, Qing Li, Cengiz S. Ozkan, Bifeng Pan and Wei Gong and has published in prestigious journals such as PLoS ONE, Scientific Reports and Environment International.

In The Last Decade

Bingfeng Chu

21 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingfeng Chu China 12 186 80 69 57 55 23 395
Kazutaka Atobe Japan 8 232 1.2× 81 1.0× 30 0.4× 11 0.2× 17 0.3× 11 432
Junhao Zhou China 13 230 1.2× 19 0.2× 113 1.6× 11 0.2× 27 0.5× 57 554
Jodie Pietruska United States 8 131 0.7× 71 0.9× 48 0.7× 6 0.1× 154 2.8× 13 478
Eva Bustamante Chile 9 68 0.4× 48 0.6× 21 0.3× 18 0.3× 9 0.2× 19 268
Zhishan Chen China 14 220 1.2× 26 0.3× 84 1.2× 10 0.2× 27 0.5× 46 441
Pu Shao China 8 111 0.6× 70 0.9× 46 0.7× 5 0.1× 16 0.3× 15 317
Lucía Speroni United States 12 124 0.7× 88 1.1× 46 0.7× 6 0.1× 7 0.1× 16 404
Yunting Zhang China 12 151 0.8× 18 0.2× 38 0.6× 7 0.1× 18 0.3× 28 317
Xiaomin Jia China 12 143 0.8× 22 0.3× 78 1.1× 15 0.3× 18 0.3× 21 518
Giorgia Urbinati France 14 307 1.7× 25 0.3× 53 0.8× 5 0.1× 10 0.2× 16 459

Countries citing papers authored by Bingfeng Chu

Since Specialization
Citations

This map shows the geographic impact of Bingfeng Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingfeng Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingfeng Chu more than expected).

Fields of papers citing papers by Bingfeng Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingfeng Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingfeng Chu. The network helps show where Bingfeng Chu may publish in the future.

Co-authorship network of co-authors of Bingfeng Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Bingfeng Chu. A scholar is included among the top collaborators of Bingfeng Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingfeng Chu. Bingfeng Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiulin, Wei Wang, Xiaonan Guo, et al.. (2025). Microfluidic-based electrically driven particle manipulation techniques for biomedical applications. RSC Advances. 15(1). 167–198. 5 indexed citations
2.
Liang, Zhiyong, Guangcun Shan, Sisi Shan, et al.. (2025). Comprehensive review on emerging nanotechnologies for combating COVID-19 and future pandemic preparedness. International Journal of Pharmaceutics. 682. 125970–125970. 1 indexed citations
3.
Han, Lu, et al.. (2021). Accelerating drug repurposing for COVID-19 treatment by modeling mechanisms of action using cell image features and machine learning. Cognitive Neurodynamics. 17(3). 803–811. 6 indexed citations
5.
Liu, Shilei, Bingfeng Chu, Xiangsong Wu, et al.. (2020). DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways. Journal of Cancer. 11(18). 5466–5477. 24 indexed citations
6.
Dong, Jie, Shaohua Li, Wei Xia, et al.. (2017). An alternative microRNA-mediated post-transcriptional regulation of GADD45A by p53 in human non-small-cell lung cancer cells. Scientific Reports. 7(1). 7153–7153. 13 indexed citations
7.
Zhang, Mingdi, Yiyu Qin, Bin Zuo, et al.. (2017). Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression. PLoS ONE. 12(2). e0167782–e0167782. 11 indexed citations
8.
Chu, Bingfeng, et al.. (2016). Downregulation of Notch-regulated Ankyrin Repeat Protein Exerts Antitumor Activities against Growth of Thyroid Cancer. Chinese Medical Journal. 129(13). 1544–1552. 5 indexed citations
9.
Zhang, Hongchen, Zhizhen Li, Bingfeng Chu, et al.. (2016). Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma. Tumor Biology. 37(6). 8305–8315. 12 indexed citations
10.
Cui, Wei, Jiaojiao Liu, Shuai Hou, et al.. (2016). Identification of ssDNA aptamers specific to clinical isolates of <italic>Streptococcus mutans</italic> strains with different cariogenicity. Acta Biochimica et Biophysica Sinica. 48(6). 563–572. 13 indexed citations
11.
Yang, Yipeng, Yunshu Lu, Tong Chen, et al.. (2016). Hypoxia promotes thyroid differentiation of native murine induced pluripotent stem cells. The International Journal of Developmental Biology. 60(4-5-6). 85–93. 6 indexed citations
12.
Zhang, Mingdi, Wei Gong, Bin Zuo, et al.. (2016). The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer. Oncotarget. 7(48). 78640–78652. 30 indexed citations
13.
Weng, Mingzhe, Wei Gong, Mingzhe Ma, et al.. (2014). Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo. Molecular Cancer. 13(1). 82–82. 22 indexed citations
14.
Cui, Wei, Yanping Luo, Jiyong Yang, et al.. (2014). [Horizontal transmission of Streptococcus mutans in caries-active preschool children].. PubMed. 34(5). 636–40. 1 indexed citations
15.
Zhu, Jian, Bingfeng Chu, Yipeng Yang, et al.. (2013). B7-H4 Expression is Associated with Cancer Progression and Predicts Patient Survival in Human Thyroid Cancer. Asian Pacific Journal of Cancer Prevention. 14(5). 3011–3015. 25 indexed citations
16.
Wang, Chenglong, Jiaojiao Liu, Shaohua Li, et al.. (2013). [Selection and identification of ssDNA aptamers specific to clinical isolates of Streptococcus mutans strains with different cariogenicity].. PubMed. 33(5). 738–41. 2 indexed citations
17.
Qin, Yiyu, Bingfeng Chu, Wei Gong, et al.. (2013). The inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis. Journal of Gastroenterology and Hepatology. 29(5). 964–972. 11 indexed citations
18.
Li, Xia, Wei Xia, Wuju Li, et al.. (2012). Identification and Expression of Small Non-Coding RNA, L10-Leader, in Different Growth Phases of Streptococcus mutans. Nucleic Acid Therapeutics. 22(3). 177–186. 21 indexed citations
19.
Liu, Jiaojiao, Chenglong Wang, Qing Xi, et al.. (2011). Dissection of the Functional Structure of Aptamer17, Which Specifically Recognizes Differentiated PC12 Cells. Nucleic Acid Therapeutics. 21(3). 225–229. 3 indexed citations
20.
Pan, Bifeng, Daxiang Cui, Ping Xu, et al.. (2009). Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems. Nanotechnology. 20(12). 125101–125101. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026